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The HLA-Cw0602 has been associated with psoriasis in different ethnic groups. But, it remains unclear whether
HLA-C is the PSORS1 gene (the psoriasis gene in the MHC). Thus, several case–control studies have been per-
formed in order to investigate whether HLA-C itself determines the susceptibility to the disease. We studied 59
Jewish patients with type I psoriasis and 79 matched controls. Polymorphic genes and markers from HLA-B
(centromeric to HLA-C) to the corneodesmosin (CDSN) gene (telomeric to HLA-C) were genotyped in order to
determine their contribution to the susceptibility to psoriasis. Neither HLA-Cw0602 nor the allele CDSNTTC were
significantly associated with psoriasis with the size of the sample studied. The genes and markers telomeric to
HLA-C such as the microsatellite C1_4_4 (OR¼ 2.6, 95% CI¼ 1.4–4.7, pc¼ 0.018) the octamer transcription factor
(OTF)-3 gene (OR¼ 2.6, 95% CI¼ 1.6–4.3, pc¼ 0.0001) and the a-helix coiled-coil rod homologue (HCR) gene
(OR¼ 2.5, 95% CI¼ 1.3–4.5, pc¼ 0.004), however, were associated with the disease. These results suggest that a
major psoriasis susceptibility gene is likely to be located within a region of 150 kb telomeric to HLA-C and cent-
romeric to the CDSN gene.
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Psoriasis vulgaris (PV) is a common inflammatory chronic
disease characterized by keratinocyte hyperproliferation,
and recruitment of T lymphocytes and mononuclear cells in
the affected skin. The causes of psoriasis are still unknown,
but there is clear evidence, from association, twin and family
studies of a strong heritable component of the disease (Fa-
ber et al, 1974; Bandrup et al, 1978). Although eight psoriasis
susceptibility loci (designated PSORS1–7 and PSORS9) and
a further 11 undesignated loci have been identified by gen-
ome-wide screening, linkage and association analysis have
defined that MHC is the major genetic determinant related to
psoriasis susceptibility (Capon et al, 2002). Within the MHC
complex, the allele HLA-Cw0602 (Cw6) is the strongest
association found in psoriasis (Brenner et al, 1978).
The possibility, however, exists that HLA-C is not the
PSORS1 (the psoriasis gene in the MHC). Thus, not all
psoriatic patients carry HLA-Cw6, especially in the case of
most oriental populations, where many affected individuals
carry HLA-Cw7. On the other hand, not all HLA-Cw6 pso-
riasis-associated haplotypes appear to confer equal risk of
psoriasis in different populations (reviewed in Elder et al,
2001). Consequently, several case–control studies of genes
located around the HLA-C locus have been performed to
determine the association of such with PV. Significant as-
sociations have been observed between psoriasis and sev-
eral genes located telomeric to HLA-C (Fig 1), namely the
octamer-binding transcription factor-3 (OTF3) gene (Gonz-
alez et al, 2000), the a-helix coiled-coil rod homologue
(HCR) gene (Asumalahti et al, 2000; O’Brien et al, 2001) and
the cornodesmosin (CDSN) gene (Allen et al, 1999; Jenisch
et al, 1999; Tazi Ahnini et al, 1999).
Comparisons of different populations with different HLA
profiles could be of value in identifying the genes involved in
PV. Very limited information exists about the association of
genes and polymorphic markers around HLA-C with pso-
riasis in the Jewish population. Interestingly, previous stud-
ies have shown that PV is not associated with HLA-Cw6 in
this population, but is associated with the alanine in position
73 (Ala73), which is present in Cw6, Cw7 and some other
alleles of HLA-C (Roitberg-Tamburg et al, 1994). The Jewish
population have a Caucasoid genetic profile, but differenc-
es have been found in allelic and HLA haplotypic frequen-
cies (Gonza´lez-Roces et al, 1994; Roitberg-Tambur et al,
1995; Martı´nez-Laso et al, 1996; Cox et al, 1999). Thus, the
study of this population could help to identify the causative
gene of this disease in the HLA region. In the present study
we performed an association analysis of several polymor-
phic markers and genes spanning a region from HLA-B, to
the CDSN gene, located 147 kb telomeric to HLA-C, in
order to map the locus for susceptibility to psoriasis in the
Jewish population.
Abbreviations: CDSN, corneodesmosin; HCR, a-helix coiled-coil
rod homologue; PV, psoriasis vulgaris; SNP, single-nucleotide
polymorphism
Copyright r 2005 by The Society for Investigative Dermatology, Inc.
928
Results
A total of 59 unrelated Israeli Jewish patients with PV and 79
unaffected population-matched controls were genotyped
for HLA-B, HLA-C, three polymorphisms of CDSN, the
polymorphismþ251 of HCR (Asumalahti et al, 2000),
the HindIII polymorphism of OTF3, the microsatellite
C1_4_4, and two non-coding SNPs close to HLA-C
(Table I and Fig 1).
No significant differences of HLA-B were found between
PV patients and controls. In particular, no significant asso-
ciation of B13 and B57 alleles with disease susceptibility
was found. A considerable incidence of the HLA-B14 in PV
patients (8.4% vs 2.5%, p¼0.051) was found. We per-
formed a high resolution typing of the B14 individuals
we found that all except two controls were B1402 (B65)
(OR¼7.1, 95% CI¼1.5–33.2, p¼ 0.01). The significance of
the association, however, was lost after correction.
The allele HLA-Cw6 was increased in patients although
not significantly (p¼0.12). The Ala 73 was also studied. Al-
though this polymorphism was increased in patients (90%
vs 78%) it was not significantly associated with the disease.
The analysis of SNP7 and SNP9, located at 7 and 4 kb
centromeric to HLA-C, revealed that they were not associ-
ated with PV. The alleles SNP7A and SNP9C, which
have been shown to be associated with PV in Caucasians
(Veal et al, 2002), are in disequilibrium with HLA-C since 34
out of 39 Cw6-positive individuals were positive for SNP7A
and SNP9C.
In order to address whether the susceptibility gene of
psoriasis was located telomeric to HLA-C, the region
between the CDSN gene and HLA-C was studied. Three
SNP at positions 619, 1236, and 1243 of this gene that
define the allele TTC, which has been found to be associ-
ated with psoriasis in several studies, were analyzed. We
found that the frequency of the allele TTC was increased in
patients although not significantly (p¼0.09) (Table I).
The HCRþ251 polymorphism was also analyzed. A
greater incidence ofþ 251T allele in PV patients was
detected (28% vs 13%, OR¼2.5, 95% CI¼1.3–4.5,
pc¼0.004). An association of the HindIII polymorphism of
the OTF3 gene with PV was found. The frequency of the
allele OTF3-B (HindIII) was 55% in patients and 31% in the
controls (OR¼ 2.6, 95% CI¼ 1.6–4.3, pc¼0.0001). In addi-
tion an association was also found between the allele 384 of
the C1_4_4 microsatellite. The frequency of this allele was
32% in patients and only 15% in controls (OR¼2.6, 95%
CI¼ 1.4–4.7, pc¼0.018).
The estimation of haplotypes was performed with the
PHASE program (Table II). No haplotypic differences were
found between patients and controls carrying the psoriasis
associated alleles, although the haplotype B65-Cw8, de-
scribed by Jenisch et al (1997) as associated with psoriasis,
was increased in patients, although not significantly
(OR¼7.8, 95%¼1.6–37, p¼0.004, pc40.3).
These data suggest that the susceptibility region to pso-
riasis is located telomeric to HLA-C, between this gene and
CDSN gene, in the Jewish population.
Discussion
The region of 150 kb between HLA-C and the CDSN gene
has been intensely studied in order to identify the psoriasis
susceptibility locus in the HLA (referred to as PSORS1).
Although the allele Cw6 shows the strongest association
with psoriasis in the HLA, evidence exists that the HLA-C
gene itself may not be the primary locus responsible for
psoriasis. Thus, there are many psoriatic patients that do
Figure 1
Region of 150 kb in the HLA class I analy-
zed in this study. The position of the genes is
indicated according to scale.
Table I. Allele frequencies of several polymorphic markers and
genes located around HLA-C in healthy controls and patients
with psoriasis in the Jewish population
Marker Allele Controls (n¼ 79) Patients (n¼ 59)
SNP7 A 53 (33.5%) 51 (43.2%)
G 105 (66.5%) 67 (56.8%)
SNP9 C 53 (33.5%) 51 (43.2%)
T 105 (66.5%) 67 (56.8%)
HLA-B B13 7 (4.4%) 8 (6.7%)
B14 4 (2.5%) 10 (8.4%)
B1402 2 (1.2%) 10 (8.4%)
B1401 2 (1.2%) –
B57 3 (1.9%) 3 (2.5%)
HLA-C Cw6 19 (12%) 23 (19.5%)
Cw7 27 (17%) 23 (19.5%)
Cw8 9 (5.7%) 12 (10.1%)
Ala73 124 (78.4%) 107 (90.6%)
C1_4_4 384 24 (15.2%) 38 (32.2%)a
OTF3 OTF3-B 50 (31.6%) 65 (55.1%)b
OTF3-A 108 (68.4%) 53 (44.9%)
HCRþ251 T 22 (13.9%) 34 (28.8%)c
C 136 (86.1%) 84 (71.2%)
CDSN 619T 128 (81%) 94 (79.6%)
1236T 103 (65.2%) 82 (69.5%)
1243C 98 (62%) 80 (67.8%)
CDSNTTC 43 (27.2%) 44 (37.3%)
The p-value has not been corrected by the number of locus studied.
aOR¼ 2.6, 95% CI¼1.4–4.7, pc¼0.018.
bOR¼ 2.6, 95% CI¼ 1.6–4.3, pc ¼0.0001.
cOR¼ 2.5, 95% CI¼ 1.3–4.5, pc ¼ 0.004.
CSDN, corneodesmosin.
GENETIC OF PSORIASIS IN THE JEWISH POPULATION 929125 : 5 NOVEMBER 2005
not carry the Cw6 allele. This could be due to two reasons:
to the locus heterogeneity and to the existence of several
HLA-C alleles that predispose to disease.
The locus heterogeneity means that several susceptibility
genes located in different chromosomes could be involved
in the disease in different patients and, therefore, Cw6 could
be responsible for the disease in only a proportion of the
patients. This does not, however, explain why different
psoriatic HLA-Cw6-bearing haplotypes (B57-Cw6, B13-
Cw6 and B37-Cw6) appear to confer different risk for
psoriasis (Jenisch et al, 1998). Moreover, a Cw6-negative
HLA-B/C haplotype (B65-Cw8) has been described that
segregates with psoriasis (Jenisch et al, 1997). Interestingly,
this haplotype corresponds to the B1402-Cw8 haplotype
which is seen to be increased in the patients of our study.
A second explanation would be that besides Cw6, other
variants within the coding sequence of the HLA-C, which
define specific antigen-binding pockets, could confer dis-
ease susceptibility. Thus, some case–control studies have
reported a significant association of a specific amino acid
residue of HLA-C (Ala-73) with psoriasis (Asahina et al,
1991; Roitberg-Tambur et al, 1994; Mallon et al, 1997);
however, association of Ala-73 with psoriasis was not found
in our study.
It has been suggested that the disease polymorphism
could lie within the regulatory region of the HLA-C; however,
neither SNP7 nor SNP9 were associated with the disease.
These polymorphisms have been described to be associ-
ated to a greater degree with psoriasis than Cw6 (Veal et al,
2002). Due to this strong association and the proximity with
HLA-C, it is to be expected that these polymorphisms
would be in disequilibrium with the disease-associated all-
eles of HLA-C.
The main evidence, however, provided by our study that
the PSORS1 gene is located telomeric to HLA-C is the fact
that the markers and genes telomeric to it, such as the
microsatellite C1_4_4 and the OTF3 and HCR genes were
found to be associated with the disease although the HLA-C
itself does not achieve significance with the size of the
sample studied. We have also found these loci to be as-
sociated with psoriasis in the Spanish population (Gonza´lez
et al, 2000; Martı´nez-Borra et al, 2003). Moreover, the HCR
gene has been described to be strongly associated with the
disease in several populations.
The analysis of the haplotypes found in this study show a
greater incidence of the haplotypes carrying the alleles
C1_4_4(384), OTF3-B and HCRþ251T in patients. The all-
ele HCRþ251T, however, is not always present in these
haplotypes. Thus, the haplotype B65-Cw8, which carries
the allele 384 of the microsatellite C1_4_4 and the
allele OTF3-B, does not carry HCRþ 251T. This allele
HCRþ251T, however, is present in the haplotypes
classically associated with psoriasis as B13-Cw6 and
B57-Cw6. Although the B65-Cw8-C1_4_4(384)-OTF3B-
251C-CDSNCTC haplotype was found in 10 cases as
opposed to only two controls, the sample size was too
small to reach statistical significance after correction for
multiple testing. As mentioned earlier, this haplotype seg-
regates with psoriasis in some pedigrees (Jenisch et al,
1997). Utilizing some of the same samples, Nair et al (2000)
previously reported overtransmission of this haplotype to
psoriatic offspring. This result, however, could not be rep-
licated in another larger sample (Cluster 17 collaboration,
2005), and association between psoriasis and this haplo-
type could not be verified in Sardinian psoriatics (Orru et al,
2005). Whether these differences reflect different gene-gene
or gene-environment interactions in different populations,
population-specific genetic variations on the same ances-
tral haplotype, or simply statistical fluctuation due to small
sample size, remains to be determined.
As for CDSN, this gene is associated with the disease in
several populations, especially the allele CDSNTTC (Tazi
Ahnini et al, 1999; Capon et al, 2003); however, we have not
found the association of this gene with PV in the Jewish
population, although an association could be found in a
larger sample. The allele CDSNTTC was present in several
haplotypes carrying the alleles associated with psoriasis,
which explains their higher incidence in patients. The lack of
Table II. Distribution of several HLA-B-Cw-CDSN haplotypes carrying the disease-associated alleles found in this study (indicated
in bold) in both patients and controls
Haplotypes Controls (n¼ 79) Patients (n¼59) OR (95% CI)
B7-Cw7-C1_4_4(384)-OTF3B-251T-CDSNTGC – 1 –
B8-Cw7- C1_4_4(384)-OTF3B-251T-CDSNTGC – 1 –
B13-Cw6- C1_4_4(384)-OTF3B-251T-CDSNTTC 5 8 1.3 (0.7–7.5)
B13-Cw7- C1_4_4(384)-OTF3B-251T-CDSNTGC 3 1 0.43 (0.04–4.3)
B37-Cw6- C1_4_4(384)-OTF3B-251T-CDSNTTC 1 3 4.1 (0.4–41)
B49-Cw7- C1_4_4(384)-OTF3B-251T-CDSNTTC – 3 –
B50-Cw6- C1_4_4(384)-OTF3B-251T-CDSNTTC 1 2 3.3 (0.2–30.9)
B57-Cw6- C1_4_4(384)-OTF3B-251T-CDSNTTC 1 2 3.3 (0.2–30.9)
B57-Cw7- C1_4_4(384)-OTF3B-251T-CDSNTTT 1 1 1.3 (0.8–21.9)
B1402-Cw8- C1_4_4(384)-OTF3B-251C-CDSNCTC 2 10 7.8 (1.6–37)a
ap¼ 0.004, pc40.3.
CSDN, corneodesmosin.
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this allele in other haplotypes, particularly in B65-Cw8,
however, could explain the lack of association of this allele
with the disease found in our study.
In summary, our study of the Jewish population suggests
that a major psoriasis susceptibility gene resides in a region
of 150 kb between HLA-C and the CDSN gene and sug-
gests that HLA-Cw6 itself may not be the causal variant.
The role(s) of the remaining genes located in this region
remain to be established, and the possibility exists that
other unidentified genes located in this region could be re-
sponsible for the disease. Thus, several open reading
frames have been found in this region (Capon et al, 2002).
Linkage disequilibrium is generally maintained in the
region telomeric to HLA-C, which hampers the confirmation
of the gene primarily associated with psoriasis. This dis-
equilibrium appears to have been broken in the Jewish
population, which supports the conclusion, reported in oth-
er studies, that HLA-C is not the psoriasis gene (Oka et al,
1999; Nair et al, 2000). Thus, the study of different popu-
lations will allow us to reduce the boundaries of the minimal
PSORS1 region.
Note. While this manuscript was under review, a fine
mapping study of the PSORS1 interval was published (Orru
et al, 2005). Typing 17 markers spanning a 525 kb interval
surrounding HLA-C, a minimal susceptibility region of 70 kb
around CDSN was obtained. This fragment, which partially
overlaps with the region defined by us, excludes HLA-C.
Patients and Methods
Patients Fifty-nine unrelated Jewish patients (39 male and 20
female) with early-onset chronic plaque psoriasis (type I) without
any other extra-epithelial manifestation of psoriasis were included
in the study. The mean age at onset of type I psoriasis was
27.4  13.9 y. Randomly matched healthy controls (79 individuals)
from the same ethnic background as the patients were also analy-
zed. All patients gave written informed consent before enrolling in
the study. The study was carried out with the approval of the ethics
committee of our hospital and conducted according to the Dec-
laration of Helsinki.
HLA-typing HLA-C and HLA-B were typed using the polymerase
chain reaction with sequence-specific primers (PCR-SSP) (Bunce
et al, 1995, 1996). High resolution typing of the B14 allele was
performed with the RELI-SSO typing kit (Dynal Biotech, Oslo, Nor-
way). The Ala73 of HLA-C was analyzed by PCR as described by
Mallon et al (1997).
Genotyping of the polymorphic markers The polymorphism of
the OTF3 gene was analysed by PCR-restriction fragment length
polymorphism (RFLP) as described previously (Gonza´lez et al,
2000). The SNP7, SNP9 and the polymorphisms of the HCR and
CDSN genes were analysed by the amplification refractory muta-
tion system (ARMS) (Newton et al, 1989) using the primers de-
scribed in Table S1.
The microsatellite C1_4_4 was studied as in Tamiya et al (1998).
Fourteen alleles were detected and were named on the basis of the
length of the amplified fragment.
Statistical analysis Allelic frequencies were calculated and the
significance of the association was determined using the w2 test
with Yate’s correction or alternatively the Fisher’s exact test when
the number of expected observations was less then five. The OR
was calculated using the cross-product ratio. Exact 95% confi-
dence intervals were obtained. The p values were corrected (pc) by
multiplying these by the number of comparisons at every locus.
Haplotypes were predicted from population data using the PHASE
2.1 program (Stephens et al, 2001).
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